Low dose-rate irradiation with [³H]-labelled valine to selectively target hypoxic cells in a human colorectal cancer xenograft model

References

• Pettersen EO, Ebbesen P, Gieling RG, et al. Targeting tumour hypoxia to prevent cancer metastasis. From biology, biosensing and technology to drug development: the METOXIA consortium. J Enzyme Inhib Med Chem. 2014;30:1–33.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Hypoxia in cancer: significance and impact on clinical outcome. Cancer Metastasis Rev. 2007;26:225–239.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989;49:6449–6465.
   PubMed Web of Science ®Google Scholar
• Shannon AM, Bouchier-Hayes DJ, Condron CM, et al. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies. Cancer Treat Rev. 2003;29:297–307.
   PubMed Web of Science ®Google Scholar
• Brown JM. Tumor hypoxia in cancer therapy. Meth Enzymol. 2007;435:297–321.
   PubMed Web of Science ®Google Scholar
• Kallman RF. The phenomenon of reoxygenation and its implications for fractionated radiotherapy. Radiology. 1972;105:135–142.
   PubMed Web of Science ®Google Scholar
• Bentzen J, Toustrup K, Eriksen JG, et al. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study. Acta Oncol. 2015;54:1001–1007.
   PubMed Web of Science ®Google Scholar
• Overgaard J. Sensitization of hypoxic tumour cells-clinical experience. Int J Radiat Biol. 1989;56:801–811.
   PubMed Web of Science ®Google Scholar
• Welz S, Monnich D, Pfannenberg C, et al. Prognostic value of dynamic hypoxia PET in head and neck cancer: results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial. Radiother Oncol. 2017;124:526–532.
   PubMed Web of Science ®Google Scholar
• Dubois L, Peeters SG, van Kuijk SJ, et al. Targeting carbonic anhydrase IX by nitroimidazole based sulfamides enhances the therapeutic effect of tumor irradiation: a new concept of dual targeting drugs. Radiother Oncol. 2013;108:523–528.
   PubMed Web of Science ®Google Scholar
• Hammond EM, Asselin MC, Forster D, et al. The meaning, measurement and modification of hypoxia in the laboratory and the clinic. Clin Oncol (R Coll Radiol). 2014;26:277–288.
   PubMed Web of Science ®Google Scholar
• Vaupel P, Mayer A. Tumor hypoxia: causative mechanisms, microregional heterogeneities, and the role of tissue-based hypoxia markers. Adv Exp Med Biol. 2016;923:77–86.
   PubMed Web of Science ®Google Scholar
• Edin NJ, Christoffersen S, Fenne S, et al. Cell inactivation by combined low dose-rate irradiation and intermittent hypoxia. Int J Radiat Biol. 2015;91:336–345.
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Bjorhovde I, Sovik A, et al. Response of chronic hypoxic cells to low dose-rate irradiation. Int J Radiat Biol. 2007;83:331–345.
   PubMed Web of Science ®Google Scholar
• Raleigh JA, Miller GG, Franko AJ, et al. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br J Cancer. 1987;56:395–400.
   PubMed Web of Science ®Google Scholar
• Kaighn ME, Narayan KS, Ohnuki Y, et al. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol. 1979;17:16–23.
   PubMedGoogle Scholar
• Vindelov LL, Christensen IJ, Nissen NI. A detergent-trypsin method for the preparation of nuclei for flow cytometric DNA analysis. Cytometry. 1983;3:323–327.
   PubMedGoogle Scholar
• Mikalsen SG, Jeppesen Edin N, Sandvik JA, et al. Separation of two sub-groups with different DNA content after treatment of T-47D breast cancer cells with low dose-rate irradiation and intermittent hypoxia. Acta Radiol. 2017;59:26–33.
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Larsen LH, Ramsing NB, et al. Pericellular oxygen depletion during ordinary tissue culturing, measured with oxygen microsensors. Cell Prolif. 2005;38:257–267.
   PubMed Web of Science ®Google Scholar
• Goddu SM, Rao DV, Howell RW. Multicellular dosimetry for micrometastases: dependence of self-dose versus cross-dose to cell nuclei on type and energy of radiation and subcellular distribution of radionuclides. J Nucl Med. 1994;35:521–530.
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Juul NO, Ronning OW. Regulation of protein metabolism of human cells during and after acute hypoxia. Cancer Res. 1986;46:4346–4351.
   PubMed Web of Science ®Google Scholar
• Mikalsen LT, Dhakal HP, Bruland OS, et al. Quantification of angiogenesis in breast cancer by automated vessel identification in CD34 immunohistochemical sections. Anticancer Res. 2011;31:4053–4060.
   PubMed Web of Science ®Google Scholar
• Kittler J, Illingworth J. Minimum error thresholding. Pattern Recognit. 1986;19:41–47.
   Web of Science ®Google Scholar
• Bedford JS, Mitchell JB. The effect of hypoxia on the growth and radiation response of mammalian cells in culture. Br J Radiol. 1974;47:687–696.
   PubMed Web of Science ®Google Scholar
• Pettersen EO, Lindmo T. Inhibition of cell-cycle progression by acute treatment with various degrees of hypoxia: modifications induced by low concentrations of misonidazole present during hypoxia. Br J Cancer. 1983;48:809–817.
   PubMed Web of Science ®Google Scholar
• Pastorekova S, Kopacek J. Tumour hypoxia: molecular mechanisms and clinical implications. Bratislava. Frankfurt am Main: VEDA Publishing House of the Slovak Academy of Sciences; Peter Lang International Academic Publishers; 2012.
   Google Scholar
• Olcina M, Lecane PS, Hammond EM. Targeting hypoxic cells through the DNA damage response. Clin Cancer Res. 2010;16:5624–5629.
   PubMed Web of Science ®Google Scholar
• Russell J, Carlin S, Burke SA, et al. Immunohistochemical detection of changes in tumor hypoxia. Int J Radiat Oncol Biol Phys. 2009;73:1177–1186.
   PubMed Web of Science ®Google Scholar
• Heijmen L, Ter Voert EG, Punt CJ, et al. Monitoring hypoxia and vasculature during bevacizumab treatment in a murine colorectal cancer model. Contrast Media Mol Imaging. 2014;9:237–245.
   PubMed Web of Science ®Google Scholar
• Wouters A, Pauwels B, Lardon F, et al. Review: implications of in vitro research on the effect of radiotherapy and chemotherapy under hypoxic conditions. Oncologist. 2007;12:690–712.
   PubMed Web of Science ®Google Scholar
• Teicher BA, Holden SA, al-Achi A, et al. Classification of antineoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaIIC murine fibrosarcoma. Cancer Res. 1990;50:3339–3344.
   PubMed Web of Science ®Google Scholar
• Chen J. Radiation quality of tritium. Radiat Prot Dosimetry. 2006;122:546–548.
   PubMed Web of Science ®Google Scholar